JPH042598B2 - - Google Patents
Info
- Publication number
- JPH042598B2 JPH042598B2 JP63065578A JP6557888A JPH042598B2 JP H042598 B2 JPH042598 B2 JP H042598B2 JP 63065578 A JP63065578 A JP 63065578A JP 6557888 A JP6557888 A JP 6557888A JP H042598 B2 JPH042598 B2 JP H042598B2
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- reaction
- ester
- general formula
- carboxyborane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 9
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 claims description 8
- -1 amine borane ester Chemical class 0.000 claims description 7
- KOXIGEBRUGYXFD-UHFFFAOYSA-N boranylformic acid Chemical compound BC(O)=O KOXIGEBRUGYXFD-UHFFFAOYSA-N 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 5
- 229910000085 borane Inorganic materials 0.000 claims description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000005270 trialkylamine group Chemical group 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 1
- 125000004969 haloethyl group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 description 21
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 5
- 150000001638 boron Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 3
- RIFGGBKCDHRFFC-UHFFFAOYSA-N CN(C)C.BC(=O)OC Chemical compound CN(C)C.BC(=O)OC RIFGGBKCDHRFFC-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- QIGLEZOOSVEDBK-UHFFFAOYSA-N NBC#N Chemical compound NBC#N QIGLEZOOSVEDBK-UHFFFAOYSA-N 0.000 description 3
- 229910052796 boron Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ICTPSNIYWSCBLS-UHFFFAOYSA-N NBC(O)=O Chemical compound NBC(O)=O ICTPSNIYWSCBLS-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001315 anti-hyperlipaemic effect Effects 0.000 description 2
- WXLFRZRGSPLPEW-UHFFFAOYSA-N boranylformic acid;n,n-dimethylmethanamine Chemical compound BC(O)=O.CN(C)C WXLFRZRGSPLPEW-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000006138 lithiation reaction Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 238000005891 transamination reaction Methods 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- RXUXPJZJUASXOS-UHFFFAOYSA-N CN(C)C.BC(=O)OCC Chemical compound CN(C)C.BC(=O)OCC RXUXPJZJUASXOS-UHFFFAOYSA-N 0.000 description 1
- LQYLGZUVSVCTFE-UHFFFAOYSA-N CN.BC(=O)OC Chemical compound CN.BC(=O)OC LQYLGZUVSVCTFE-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 1
- DSVPTPXKGOQDDQ-UHFFFAOYSA-N N.BC(=O)OC Chemical compound N.BC(=O)OC DSVPTPXKGOQDDQ-UHFFFAOYSA-N 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- MUTDNIUYABKXLN-UHFFFAOYSA-N azane;boranylformic acid Chemical class [NH4+].BC([O-])=O MUTDNIUYABKXLN-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- RRMCILTYBQCEHE-UHFFFAOYSA-N boranylformic acid;methanamine Chemical compound NC.BC(O)=O RRMCILTYBQCEHE-UHFFFAOYSA-N 0.000 description 1
- BTSWWBIRVRVZNU-UHFFFAOYSA-N boranylformic acid;n-methylmethanamine Chemical compound CNC.BC(O)=O BTSWWBIRVRVZNU-UHFFFAOYSA-N 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical group CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical group CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- SSVSTIGWSOEKDK-UHFFFAOYSA-N methoxyborane Chemical compound BOC SSVSTIGWSOEKDK-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
[産業上の利用分野]
本発明は、抗腫瘍活性又は脂血低下
(hypolipidemic)活性を有する生物学的活性物
質としてのアミノ酸ホウ素アナログのエステルの
製法に係る。
[従来の技術]
アミノ酸のホウ素アナログは当業界では広く知
られている。例えばフアーマス−テイカルサイエ
ンス誌(Journal of Pharmaceutical
Sciences)、1981年3月、No.3、V.70、アミノシ
アノボラン、アミノカルボキシボラン及び関連化
合物の抗高脂質血症活性(Antihyperlipidemic
Activity of Amino Cyanoboranes、Amino
Carboxyboranes and Related Compounds)で
はアミノシアノボランの抗高脂質血症活性が論じ
られている。
アミノ酸のホウ素アナログに関して発行された
米国特許としては第4209510号;第4312989号;第
4368194号が挙げられる。
アミノ酸のホウ素アナログは、対応する酸及び
アルコール類をジクロロメタン中室温でジシクロ
ヘキシルカルボジイミド(DCC)の存在下で縮
合させることにより、または以下に開示したクロ
ロホルメートを用いる方法によつて製造し得る。
代表的エステル物質の製造
1 (CH3)3NBH2COOH及び無水エタノールの
溶液をDCCと共に室温で6日間脱水処理する
ことによりトリメチルアミン−カルボエトキシ
ボラン(CH3)3NBH2COOC2H5を製造した。
この方法での収率は45%であつた。この甘い香
りのエステルは揮発性と水溶性が比較的高く、
それがこの方法の低収率の原因になつたと考え
られる。
2 (CH3)3NBH2COOH及びCH3−OHを室温
で1週間DCCと縮合させることにより82%の
収率でトリメチルアミン−カルボメトキシボラ
ン(CH3)3NBH2COOCH3を製造した。反応時
間を2週間に延長すると収率も98%に増大し
た。
3 (CH3)3NBH2COOH3と8倍の過剰量(重
量で)の(CH3)2NHとのアミノ交換反応をガ
ラス製耐圧反応容器内室温で2週間行なうこと
によりジメチルアミン−カルボメトキシボラン
(CH3)2NHBH2COOCH3を67%の収率で製造
した。H2Oによる洗浄と真空ポンピングとに
より生成混合物中の未反応出発エステル8%を
除去した。出発材料及び生成物中のエステル結
合は過剰アミンによつて開裂しなかつた。変形
例として(CH3)2NHBH2COOCH及びCH3OH
とDCCとを室温で4日間縮合反応させること
もできた。この反応法では収率が極めて低かつ
た(8%)。
4 CH3NH2BH2COOH及びCH3OHをDCCと室
温で6日間縮合させることによりメチルアミン
−カルボメトキシボラン、
CH3NH2BH2COOCH3を製造した。この反応
による収率は21%であつた。
5 化合物4の製法と同様の方法で、
(CH3)3NBH2COOH及びHOCH2CH2Clを
DCCと室温で1週間縮合させることによりト
リメチルアミン−(カルボ−2−クロロエトキ
シ)ボラン((CH3)3NBH2COOCH2CH2Cl(5)
を製造した。この反応による収率は61%であつ
た。
6 ステンレス鋼製耐圧容器内で
(CH3)3NBH2COOCH3と過剰の液体NH3との
間のアミン交換反応を室温で2週間生起させる
ことによりアンモニア−カルボメトキシボラ
ン、H3−NBH2COOCH3を製造した。
7 エーテル中乾燥N2の存在下で
(CH3)3NBH2COOHをn−C4H9Liによりリチ
ウム化(lithiation)し、次いでリチウム塩
(未単離)を室温で16時間(CH3)3SiClと反応
させることによりトリメチルアミン−(カルボ
トリメチルシロキシ)ボラン、
(CH3)3NBH2COOSi(CH3)3を製造した。操作
後減圧蒸留にかけると58%のシリルエステルが
透明で感湿性の液体として得られた。これは放
置しておくと凝固した。
これら化合物の総てを元素分析と、IR、
HNMR及びBNMR分光分析とにかけて特性を調
べた。
これらエステルの物理的データ及びスペクトル
データを表に示す。IRスペクトルはB−H及
びC=0の特徴的吸収を示した。プロトン及びホ
ウ素のNMRスペクトルデータはこれら化合物の
表に示した式と調和していた。IRスペクトルは
パーキン−エルマー(Perkin−Elmer)297スペ
クトロメータで記録した。固体試料はKBrデイ
スクとして、NaClデイスク間のヌジヨールマル
(Nujol mulls)として、又は適切な溶媒中の溶
液として調製した。油類は明確に記録された。プ
ロトン及びホウ素NMRスペクトルは夫々バリア
ン(Varian)EM360Aスペクトルメータ及びジ
エオル(JEOL)FX90Qスペクトロメータで得
た。元素分析はテネシー州ノツクスビルのガルブ
レイスラボラトリー社(Galbraith
Laboratories、Inc.)又はニユーヨーク州ウツド
サイドのシユワルツコフマイクロアナリテイカル
ラボラトリー社(Schwarzkopf
Microanalytical Laboratory Inc.)によつて行
なわれた。
[Industrial Field of Application] The present invention relates to a process for the preparation of esters of amino acid boron analogues as biologically active substances having antitumor or hypolipidemic activity. [Prior Art] Boron analogs of amino acids are widely known in the art. For example, Journal of Pharmaceutical Science.
Antihyperlipidemic Activity of Aminocyanoborane, Aminocarboxyborane and Related Compounds, March 1981, No. 3, V.70.
Activity of Amino Cyanoboranes, Amino
Carboxyboranes and Related Compounds) discusses the antihyperlipidemic activity of aminocyanoboranes. U.S. patents issued regarding boron analogs of amino acids include No. 4209510; No. 4312989;
No. 4368194 is mentioned. Boron analogs of amino acids can be prepared by condensation of the corresponding acids and alcohols in dichloromethane at room temperature in the presence of dicyclohexylcarbodiimide (DCC) or by the method using chloroformates disclosed below. Preparation of Representative Ester Substances 1 Trimethylamine-carboethoxyborane ( CH3 ) 3NBH2COOC2H5 is prepared by dehydrating a solution of (CH3)3NBH2COOH and absolute ethanol with DCC at room temperature for 6 days. did.
The yield with this method was 45%. This sweet-smelling ester has relatively high volatility and water solubility;
This is believed to be the cause of the low yield of this method. Trimethylamine- carbomethoxyborane ( CH3 ) 3NBH2COOCH3 was prepared in 82% yield by condensing 2 (CH3) 3NBH2COOH and CH3 - OH with DCC for one week at room temperature . The yield also increased to 98% when the reaction time was extended to 2 weeks. 3 (CH 3 ) 3 NBH 2 COOH 3 and an 8-fold excess (by weight) of (CH 3 ) 2 NH to conduct the transamination reaction in a glass pressure-resistant reaction vessel at room temperature for 2 weeks to form dimethylamine-carbohydrate. Methoxyborane (CH3)2NHBH2COOCH3 was produced in 67% yield . Washing with H 2 O and vacuum pumping removed 8% of the unreacted starting ester in the product mixture. Ester bonds in the starting material and product were not cleaved by excess amine. As a variant (CH 3 ) 2 NHBH 2 COOCH and CH 3 OH
It was also possible to carry out a condensation reaction between DCC and DCC at room temperature for 4 days. This reaction method gave a very low yield (8%). 4 Methylamine - carbomethoxyborane by condensing CH3NH2BH2COOH and CH3OH with DCC at room temperature for 6 days,
CH3NH2BH2COOCH3 was produced . The yield from this reaction was 21%. 5 Using the same method as for compound 4, (CH 3 ) 3 NBH 2 COOH and HOCH 2 CH 2 Cl were
Trimethylamine-(carbo - 2-chloroethoxy)borane (( CH3 ) 3NBH2COOCH2CH2Cl (5)) by condensation with DCC for 1 week at room temperature
was manufactured. The yield from this reaction was 61%. 6 Ammonia-carbomethoxyborane, H3 - NBH2 , was produced by a transamination reaction between ( CH3 ) 3NBH2COOCH3 and excess liquid NH3 at room temperature for 2 weeks in a stainless steel pressure vessel. COOCH 3 was manufactured. 7 Lithiation of ( CH3 ) 3NBH2COOH with n- C4H9Li in the presence of dry N2 in ether, then lithiation of the lithium salt ( unisolated ) at room temperature for 16 h (CH3 ) ) 3 trimethylamine-(carbotrimethylsiloxy)borane by reacting with SiCl,
( CH3 ) 3NBH2COOSi ( CH3 ) 3 was produced. After the operation, vacuum distillation yielded 58% of the silyl ester as a clear, moisture-sensitive liquid. This solidified when left alone. All of these compounds were analyzed by elemental analysis, IR,
The properties were investigated by HNMR and BNMR spectroscopy. The physical and spectral data of these esters are shown in the table. The IR spectrum showed characteristic absorptions of B-H and C=0. Proton and boron NMR spectral data were consistent with the formulas shown in the table for these compounds. IR spectra were recorded on a Perkin-Elmer 297 spectrometer. Solid samples were prepared as KBr disks, as Nujol mulls between NaCl disks, or as solutions in appropriate solvents. Oils were clearly recorded. Proton and boron NMR spectra were obtained on a Varian EM360A spectrometer and a JEOL FX90Q spectrometer, respectively. Elemental analysis was performed by Galbraith Laboratory, Knoxville, Tennessee.
Laboratories, Inc.) or Schwarzkopf Microanalytical Laboratories, Woodside, New York.
Microanalytical Laboratory Inc.).
【表】
a (C2H5)2O.BF3を外部標準として使用した。
この表に示されている化学シフトは総て前記標
準から(負に)ずれていた(upfield)。
血清脂質スクリーニング
実験の間CF1雄マウス(30g)に齧歯動物用ラ
ボラトリーフードを与え、水も任意に与えた。本
発明の化合物を1%カルボキシメチルセルロース
−水に懸濁させ均質化(ホモゲナイズ)した。用
量はこれらマウスの各週の体重に基づいて計算し
た。テスト化合物を20mg/Kg/日の割合で腹腔内
(ip)投与した。9日目及び16日目に、アルカリ
を含まない非ヘパリン化毛様細管への尾部静脈放
血により採血を行ない、3分間遠心分離処理して
血清を得た。非溶血血清の30ml試料を一対使用
し、ネス(Ness)他によりクリヌ、ケム、アク
タ(Clin、Chem、Acta)誌、第10巻、p229
(1964年)に記載のリーバーマン−バーチヤード
(Liebermann−Burchard)反応を変形して血清
コレステロールレベル(ミリグラムパーセント)
を調べた。別のグループのマウスを14日目に放血
処理し、25ml試料を用いて血清トリグリセリドレ
ベル(ミリグラムパーセント)を測定した。
血清テスト結果を表2に示す。示されている値
はコントロールに対するパーセントの値である。
抑制パーセンテージ即ち化合物の効果は100から
前記のコントロールに対するパーセンテージを差
引くことによつて求められる。[Table] a (C 2 H 5 ) 2 O.BF 3 was used as an external standard.
All chemical shifts shown in this table are (negatively) upfield from the standard. Serum Lipid Screening CF 1 male mice (30 g) were fed rodent laboratory food and had water ad libitum during the experiment. The compound of the present invention was suspended in 1% carboxymethylcellulose-water and homogenized. Doses were calculated based on the weekly weight of these mice. Test compounds were administered intraperitoneally (ip) at a rate of 20 mg/Kg/day. On days 9 and 16, blood was collected by tail vein exsanguination into alkali-free, non-heparinized capillary tubules and centrifuged for 3 minutes to obtain serum. Using a pair of 30 ml samples of non-hemolyzed serum, the procedure was performed by Ness et al., Clin, Chem, Acta, Vol. 10, p. 229.
Serum cholesterol level (percent milligrams) using a modification of the Liebermann-Burchard reaction described in (1964).
I looked into it. Another group of mice was exsanguinated on day 14, and 25 ml samples were used to measure serum triglyceride levels (percent milligrams). Serum test results are shown in Table 2. Values shown are percentages of control.
The percentage inhibition, or effect of the compound, is determined by subtracting the percentage relative to the control from 100.
【表】
これらの化合物は総て血清コレステロール及び
トリグリセリドに関して或る程度の制御活性を示
す。特にトリメチルアミンカルボメトキシボラン
は血清トリグリセリドに関して77%の抑制効果を
示した。ジヤーナル オブ フアーマス−テイカ
ル サイエンス(J.Pharm.Sci.)、第70巻、第339
頁(1981年)に報告されているように、対応する
エチルエステルは20mg/Kgの投与量で43%の抑制
しか示さないことに比較してみると上記の効果は
顕著である。
前述の如きアミノ酸のホウ素アナログのエステ
ルの製造は十分な量のテスト用物質を製造するた
めの技術を提供した。しかしながら対応の酸及び
アルコール類をCH2Cl2中室温でDCC存在下で縮
合させることにより前記化合物を製造する従来方
法では反応時間が非常に長い。この反応の収率は
通常良好ないしは中程度であるが、1週間以上も
の時間を必要とする。更にこのエステルは、除去
しなければならない副産物としてジシクロヘキシ
ルウレアを含む。分留晶出及び溶媒抽出による所
望生成物の分離は所望のエステルと該副産物とが
互に類似した溶解特性を有するため時間がかかり
困難である。
前記エステルを製造するための別の合成技術と
して、米国特許第4368194号に記載の如きテトラ
フルオロボレート化合物でのトリアルキルアミン
カルボキシボランの処理がある。この方法は出発
カルボキシボランがトリアミン置換基を有する場
合の化合物には効果的であつたが、ジアミン、モ
ノアミン又はアンモニアのカルボキシボランには
効果がない。これはボラン中のホウ素上の水素が
加水分解するためである。
本発明のエステル製造法
より効果的でより一般的に使用される新規な合
成法を以下に記載する。この新規な合成法は、ア
ミンカルボキシボランの窒素上に水素原子がある
かないかに関係なくエステルを製造するのに使用
することができる。通常所望のエステルは、混合
カルボン酸−炭酸無水物を穏やかな条件下で反応
させることにより製造する。この改良された合成
法では、当モル量のアミンカルボキシボラン、ア
ルキルクロロホルメート及びトリアルキルアミン
を塩化メチレン中で低温即ち−10〜+10℃の温度
で混合することにより脱カルボキシル化を迅速に
生起させて所望のエステル生成物を得る。
[実施例]
塩化メチレン100mlにアミンカルボキシボラン
0.01モルとトリエチルアミン0.011モルとを溶解
した溶液にアルキルクロロホルメート0.01モルと
ジメチルアミノピリジン0.001モルとを加えた。
常時攪拌しながらこの混合物を1時間0℃に維持
した。二酸化炭素の発生を伴いながら反応はスム
ーズに進んだ。1時間後に該溶液を20mlの水で2
度洗浄し、硫酸マグネシウムを用いて乾燥した。
得られた物質を濃縮して純エステルにした。
種々の出発材料を用いて、種々の出発化合物を
使用した基本構造(R)3NBH2COOR′のエステ
ル類を製造した。Rがメチルまたはエチルを表わ
す場合のエステル類を製造した。アミノ窒素に結
合した有機基の数は1〜3であつた。
R′がメチル、エチル、コレステリル、ベンジ
ル、フエニル、臭化エチル及び塩化エチルを表わ
す場合のエステル類を製造した。
以下、本発明の実施例をより具体的な実験例を
参照しつつ説明する。
トリメチルアミン−メトキシカルボニルボラン
(3a)の製造
トリメチルアミン−カルボキシボラン(1.1696
g、0.01mol)及びトリエチルアミン(1.1131g、
0.011mol)のジクロロメタン溶液(100ml、0
℃)を攪拌し、これに、メチルクロロホルメート
(0.945g、0.01mol)を加え、次に4−ジメチル
アミノピリジン(0.1222g、0.001mol)を加え
た。得られた混合物を0℃にて1時間攪拌し、そ
の後、水で洗浄し(2×20ml)、硫酸マグネシウ
ムで乾燥させ、濃縮することにより、以下の表3
中、3aで示す純粋なエステルが得られた。収率
1.1g(84%)。m.p.=90〜92℃。
分析データ
C5H14BNO2(76.0)
計算値 C45.85 H10.77 N10.69
実測値 C45.95 H10.99 N10.56
IR(CDCl3);ν=2950(CH);2385(BH);
1660(CO)cm-1、 1H−NMR(CDCl3);δ=2.72
[s、(CH3)3N]3.48ppm(s、OCH3)、 11B−
NMR[CDCl3/(C2H5)2OBF3]:δ=−9.09ppm
(t、JB-H=99Hz).
同様な方法により、表3中の他の化合物を製造
した。但し、化合物5a及び7aについては、トリ
メチルアミンカルボキシボランの代りに、同モル
量のジメチルアミンカルボキシボラン及びメチル
アミンカルボキシボランを夫々用いた。
また、3eについては、室温にて1日かけて反応
を行つた。TABLE All these compounds exhibit some degree of regulatory activity with respect to serum cholesterol and triglycerides. In particular, trimethylaminecarbomethoxyborane showed a 77% inhibitory effect on serum triglycerides. Journal of Pharmaceutical Sciences (J.Pharm.Sci.), Volume 70, No. 339
This effect is remarkable when compared to the corresponding ethyl ester, which showed only 43% inhibition at a dose of 20 mg/Kg, as reported by Page (1981). The production of esters of boron analogs of amino acids as described above provided a technique for producing sufficient quantities of test materials. However, the conventional method of preparing said compounds by condensing the corresponding acids and alcohols in CH 2 Cl 2 at room temperature in the presence of DCC requires very long reaction times. The yield of this reaction is usually good to moderate, but it takes a week or more. Additionally, this ester contains dicyclohexylurea as a by-product that must be removed. Isolation of the desired product by fractional crystallization and solvent extraction is time consuming and difficult because the desired ester and the by-product have similar solubility characteristics. Another synthetic technique for making the esters is the treatment of trialkylamine carboxyborane with a tetrafluoroborate compound as described in US Pat. No. 4,368,194. This method was effective for compounds where the starting carboxyborane had a triamine substituent, but not for diamine, monoamine or ammonia carboxyboranes. This is because hydrogen on boron in borane is hydrolyzed. Process for Preparing Ester of the Invention A new, more effective and more commonly used synthetic method is described below. This new synthetic method can be used to prepare esters with or without a hydrogen atom on the nitrogen of the amine carboxyborane. The desired ester is usually prepared by reacting mixed carboxylic acid-carbonic anhydrides under mild conditions. In this improved synthesis method, decarboxylation occurs rapidly by mixing equimolar amounts of amine carboxyborane, alkyl chloroformate, and trialkyl amine in methylene chloride at low temperatures, i.e., between -10 and +10°C. to obtain the desired ester product. [Example] Amine carboxyborane in 100ml of methylene chloride
0.01 mole of alkyl chloroformate and 0.001 mole of dimethylaminopyridine were added to a solution containing 0.01 mole of triethylamine and 0.011 mole of triethylamine.
The mixture was maintained at 0° C. for 1 hour with constant stirring. The reaction proceeded smoothly with the production of carbon dioxide. After 1 hour, the solution was diluted with 20 ml of water.
It was washed twice and dried using magnesium sulfate.
The resulting material was concentrated to the pure ester. Various starting materials were used to prepare esters of basic structure (R) 3 NBH 2 COOR' using various starting compounds. Esters were prepared where R represents methyl or ethyl. The number of organic groups bonded to the amino nitrogen was 1-3. Esters were prepared where R' represents methyl, ethyl, cholesteryl, benzyl, phenyl, ethyl bromide and ethyl chloride. Examples of the present invention will be described below with reference to more specific experimental examples. Production of trimethylamine-methoxycarbonylborane (3a) Trimethylamine-carboxyborane (1.1696
g, 0.01 mol) and triethylamine (1.1131 g,
0.011 mol) in dichloromethane solution (100 ml, 0
C) and to this was added methyl chloroformate (0.945 g, 0.01 mol) followed by 4-dimethylaminopyridine (0.1222 g, 0.001 mol). The resulting mixture was stirred at 0 °C for 1 h, then washed with water (2 x 20 ml), dried over magnesium sulfate, and concentrated to give the following Table 3:
In the process, the pure ester designated 3a was obtained. yield
1.1g (84%). mp = 90-92℃. Analysis data C 5 H 14 BNO 2 (76.0) Calculated value C45.85 H10.77 N10.69 Actual value C45.95 H10.99 N10.56 IR (CDCl 3 ); ν = 2950 (CH); 2385 (BH) ;
1660 (CO) cm -1 , 1 H-NMR (CDCl 3 ); δ=2.72
[s, (CH 3 ) 3 N] 3.48 ppm (s, OCH 3 ), 11 B−
NMR [ CDCl3 /( C2H5 ) 2OBF3 ]: δ = -9.09ppm
(t, J BH = 99Hz). Other compounds in Table 3 were prepared in a similar manner. However, for Compounds 5a and 7a, the same molar amounts of dimethylamine carboxyborane and methylamine carboxyborane were used instead of trimethylamine carboxyborane, respectively. Regarding 3e, the reaction was carried out at room temperature for one day.
【表】
この方法を用いると多様のエステル物質が迅速
に且つ高収率で得られる。
以上、アミノ酸のホウ素アナログの新規の改良
されたエステル製造法について説明したきたが、
この種のエステル類は血清コレステロール及びト
リグリセリドを減少させる効果を示す。[Table] Using this method, a variety of ester materials can be obtained rapidly and in high yields. Having described above a new and improved method for producing esters of boron analogs of amino acids,
Esters of this type exhibit a reducing effect on serum cholesterol and triglycerides.
Claims (1)
チル又はエチルを示し(但し、少なくともR1、
R2及びR3のうちの一つはメチル又はエチルであ
る。)、R′はメチル、エチル、コレステリル、フ
エニル、ベンジル又はハロエチルを示す。]を有
するアミンボランエステルの製造方法であつて、 等モル量のアミンカルボキシボラン及び一般式: ClCOOR′ (式中、R′は上記定義と同じ。) の化合物並びに少なくとも等モル量の一般式: R1R2R3N (式中、R1、R2及びR3は上記定義と同じ。)のト
リアルキルアミンを相容性溶媒中で混合し、 該反応混合物からアミンボランエステルを単離
する段階から成る前記方法。 2 反応混合物に触媒量のジメチルアミノピリジ
ンを添加することを特徴とする特許請求の範囲第
1項に記載の方法。 3 トリアルキルアミンがトリメチルアミンまた
はトリエチルアミンであることを特徴とする特許
請求の範囲第1項に記載の方法。 4 溶媒が塩化メチレンであることを特徴とする
特許請求の範囲第1項に記載の方法。 5 反応を−10℃〜+10℃の温度で行なうことを
特徴とする特許請求の範囲第1項に記載の方法。[Claims] 1 General formula: R 1 R 2 R 3 NBH 2 COOR' [In the formula, R 1 , R 2 and R 3 each independently represent hydrogen, methyl or ethyl (provided that at least R 1 ,
One of R 2 and R 3 is methyl or ethyl. ), R' represents methyl, ethyl, cholesteryl, phenyl, benzyl or haloethyl. ] A method for producing an amine borane ester having an equimolar amount of an amine carboxyborane and a compound of the general formula: ClCOOR′ (wherein R′ is as defined above) and at least an equimolar amount of a compound of the general formula: A trialkylamine of R 1 R 2 R 3 N (wherein R 1 , R 2 and R 3 are as defined above) is mixed in a compatible solvent, and the amine borane ester is isolated from the reaction mixture. The method comprises the steps of: 2. Process according to claim 1, characterized in that a catalytic amount of dimethylaminopyridine is added to the reaction mixture. 3. The method according to claim 1, wherein the trialkylamine is trimethylamine or triethylamine. 4. The method according to claim 1, wherein the solvent is methylene chloride. 5. The method according to claim 1, characterized in that the reaction is carried out at a temperature of -10°C to +10°C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63065578A JPS63264490A (en) | 1984-10-25 | 1988-03-18 | Manufacture of amineborane ester |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/664,647 US4647555A (en) | 1984-10-25 | 1984-10-25 | Esters of boron analogues of amino acids |
JP63065578A JPS63264490A (en) | 1984-10-25 | 1988-03-18 | Manufacture of amineborane ester |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63264490A JPS63264490A (en) | 1988-11-01 |
JPH042598B2 true JPH042598B2 (en) | 1992-01-20 |
Family
ID=26406720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63065578A Granted JPS63264490A (en) | 1984-10-25 | 1988-03-18 | Manufacture of amineborane ester |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63264490A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9352498B2 (en) | 2009-10-09 | 2016-05-31 | Ube Industries, Ltd. | Method of manufacturing polyimide film and tenter apparatus |
-
1988
- 1988-03-18 JP JP63065578A patent/JPS63264490A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9352498B2 (en) | 2009-10-09 | 2016-05-31 | Ube Industries, Ltd. | Method of manufacturing polyimide film and tenter apparatus |
Also Published As
Publication number | Publication date |
---|---|
JPS63264490A (en) | 1988-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH1192423A (en) | Production of methyl ester or ethyl ester of trifluoroacetic acid and chlorodifluoroacetic acid | |
US4647555A (en) | Esters of boron analogues of amino acids | |
JP2013227345A (en) | Synthesis of half ester | |
JPH042598B2 (en) | ||
JP2009518380A (en) | Preparation of 2-chloroethoxy-acetic acid-N, N-dimethylamide | |
US3910958A (en) | Process for preparing arylacetic acids and esters thereof | |
JPH0159249B2 (en) | ||
JPS6120540B2 (en) | ||
RU2021276C1 (en) | Method of synthesis of trialkylgermanium esters of 2-trialkylgermyloxy-2-phenylacetic acid | |
JPH0142253B2 (en) | ||
SU469683A1 (en) | Method for preparing oxyphenyl methacrylic esters containing ketone or aldehyde groups | |
JPS597712B2 (en) | Method for producing γ-lactone derivative | |
US4714777A (en) | Cyclopropanone hydrate derivatives | |
EP0003866B1 (en) | 3-azabicyclo(3.1.0)hexane derivatives and a process for their preparation | |
SU857118A1 (en) | Method of preparing alpha-propargyl-substituted phenylhydrazines | |
JP3777407B2 (en) | Method for producing carboxylic acid derivative | |
SU740784A1 (en) | Method of preparing 2-halogenvinyloxyorganosilanes | |
US4740637A (en) | Process for hydroxymethylation | |
US4806684A (en) | Process for the preparation of bromofluoroacetic acids | |
JP2697198B2 (en) | Method for producing 2-hydroxy-3,3,3-trifluoropropionitrile | |
SU399510A1 (en) | METHOD FOR OBTAINING ALKILOV B1 ETHER | |
JPS6257181B2 (en) | ||
JPS6032783A (en) | Fluorine-containing coumarins | |
SU810677A1 (en) | Method of preparing n-aryl-n-benzalhydrazides of aroylacetic acids | |
JPH0655731B2 (en) | Method for producing styrene oxide |